Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell P Levesque

Showing results (121-130 of 203) with videos related to

Pageof 21
Sort By:
Cell Reports|February 9, 2022
Mycobacterial infection aggravates Helicobacter pylori-induced gastric preneoplastic pathology by redirection of de novo induced Treg cellsMariela Artola-Borán, Angela Fallegger, Martina Priola, et al.
Melanoma Research|May 17, 2017
Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in SwitzerlandJoanna Mangana, Phil F Cheng, Corina Kaufmann, et al.
Cells|March 13, 2024
CD112 Supports Lymphatic Migration of Human Dermal Dendritic CellsNeda Haghayegh Jahromi, Anastasia-Olga Gkountidi, Victor Collado-Diaz, et al.
JCO Precision Oncology|February 25, 2026
Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort AnalysisBenedict Gosztonyi, Tarun Mehra, Gabriele Gut, et al.
Cancers|June 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints TargetedLukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko, et al.
Frontiers in Oncology|May 2, 2022
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint InhibitionSimon Burgermeister, Hubert S Gabryś, Lucas Basler, et al.
The Journal of Experimental Medicine|October 28, 2020
Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesisMin Ma, Soumitra Ghosh, Daniele Tavernari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2025
Circulating tumor DNA is prognostic of patient outcome and enables therapy monitoring in metastatic uveal melanomaEgle Ramelyte, Julian Kött, Aleigha R Lawless, et al.
Nature Communications|January 25, 2024
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoidesYun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, et al.
Genome Biology|April 18, 2015
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanomaPhil F Cheng, Olga Shakhova, Daniel S Widmer, et al.
Pageof 21

Showing results (121-130 of 203) with videos related to

Sort By:
Pageof 21
Cell Reports|February 9, 2022
Mycobacterial infection aggravates Helicobacter pylori-induced gastric preneoplastic pathology by redirection of de novo induced Treg cellsMariela Artola-Borán, Angela Fallegger, Martina Priola, et al.
Melanoma Research|May 17, 2017
Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in SwitzerlandJoanna Mangana, Phil F Cheng, Corina Kaufmann, et al.
Cells|March 13, 2024
CD112 Supports Lymphatic Migration of Human Dermal Dendritic CellsNeda Haghayegh Jahromi, Anastasia-Olga Gkountidi, Victor Collado-Diaz, et al.
JCO Precision Oncology|February 25, 2026
Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort AnalysisBenedict Gosztonyi, Tarun Mehra, Gabriele Gut, et al.
Cancers|June 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints TargetedLukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko, et al.
Frontiers in Oncology|May 2, 2022
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint InhibitionSimon Burgermeister, Hubert S Gabryś, Lucas Basler, et al.
The Journal of Experimental Medicine|October 28, 2020
Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesisMin Ma, Soumitra Ghosh, Daniele Tavernari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2025
Circulating tumor DNA is prognostic of patient outcome and enables therapy monitoring in metastatic uveal melanomaEgle Ramelyte, Julian Kött, Aleigha R Lawless, et al.
Nature Communications|January 25, 2024
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoidesYun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, et al.
Genome Biology|April 18, 2015
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanomaPhil F Cheng, Olga Shakhova, Daniel S Widmer, et al.
Pageof 21